Fairfield, Bush & Co’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-10,690
Closed -$461K 138
2015
Q4
$461K Buy
+10,690
New +$461K 0.16% 96
2015
Q3
Sell
-12,344
Closed -$420K 152
2015
Q2
$420K Sell
12,344
-61,970
-83% -$2.11M 0.13% 117
2015
Q1
$2.63M Sell
74,314
-10,020
-12% -$355K 0.77% 43
2014
Q4
$2.87M Sell
84,334
-40,420
-32% -$1.38M 0.82% 39
2014
Q3
$4.81M Buy
124,754
+3,020
+2% +$116K 1.38% 25
2014
Q2
$4.74M Buy
121,734
+5,735
+5% +$223K 1.39% 25
2014
Q1
$3.97M Buy
+115,999
New +$3.97M 1.87% 23